Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma.

Authors	Mathias Oymanns, Michael Daum-Marzian, Aliyah Bellm, Khaled Elsayad, Hans T Eich, Chalid Assaf
Journal	The British journal of dermatology (Br J Dermatol) Vol. 188 Issue 1 Pg. 145-146 (01 23 2023) ISSN: 1365-2133 [Electronic] England
PMID	36689504 (Publication Type: Journal Article)
Chemical References	Brentuximab Vedotin Immunoconjugates Ki-1 Antigen
Topics	Humans Brentuximab Vedotin Electrons Immunoconjugates Lymphoma, T-Cell, Cutaneous (pathology) Skin Neoplasms (pathology) Ki-1 Antigen

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!